Connecticut Innovations Closes FY 2020 with $43.2 in Total Investments
Deals leveraged more than $436 million in outside capital
New Haven, CT – September 23, 2020 – Connecticut Innovations (CI), Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies, today announced final investment figures from its recently completed fiscal year.
Between July 1, 2019, and June 30, 2020, CI invested $43.2 million in Connecticut-based, early-stage companies via 135 individual transactions. In terms of investment breakdown, CI invested $25.8 million in bioscience and healthcare companies, $15.9 million in information technology companies and $1.5 million in other Connecticut-based companies. CI’s transactions also leveraged an additional $436 million in outside capital.
“Following another active year of investment and engagement, CI continues to add to its portfolio of exciting, high-potential companies,” said David Wurzer, chief investment officer and executive vice president at Connecticut Innovations. “Even in this challenging climate, we continue to see substantial progress being made and milestones achieved by many of our portfolio companies across a broad range of technology categories. We look forward to supporting their growth in the coming year.”
About Connecticut Innovations
Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. CI provides venture capital and strategic support for early-stage technology companies, financial support for innovation and collaboration, and connections to its well-established network of partners and professionals. For more information, please visit www.ctinnovations.com.